261201800023C (N01) | |||
---|---|---|---|
Title | Topic 371 - Phase I SBIR Contract - Valudation and Optimization of RP-185 as Adjuvant to Exploit the Immune Response Generated by Radiation | ||
Institution | RIPTIDE BIOSCIENCE, INC., , | ||
Principal Investigator | -, - | NCI Program Director | N/A |
Cancer Activity | N/A | Division | N/A |
Funded Amount | $299,847 | Project Dates | null - null |
Fiscal Year | 2018 | Project Type | Contract |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) Digestive Diseases (100.0%) Metastasis (33.0%) |
Pancreas (100.0%) | ||
Research Type | |||
Resources and Infrastructure Related to Treatment and the Prevention of Recurrence | |||
Abstract | |||
No abstract available. |